Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 2403

1.

Breast Cancer Stem-Like Cells Are Inhibited by Diosgenin, a Steroidal Saponin, by the Attenuation of the Wnt β-Catenin Signaling via the Wnt Antagonist Secreted Frizzled Related Protein-4.

Bhuvanalakshmi G, Basappa, Rangappa KS, Dharmarajan A, Sethi G, Kumar AP, Warrier S.

Front Pharmacol. 2017 Mar 20;8:124. doi: 10.3389/fphar.2017.00124. eCollection 2017.

2.

Anti-Cancer Phytometabolites Targeting Cancer Stem Cells.

Torquato HF, Goettert MI, Justo GZ, Paredes-Gamero EJ.

Curr Genomics. 2017 Apr;18(2):156-174. doi: 10.2174/1389202917666160803162309. Review.

PMID:
28367074
3.

Targeting Signaling Pathways in Cancer Stem Cells for Cancer Treatment.

Koury J, Zhong L, Hao J.

Stem Cells Int. 2017;2017:2925869. doi: 10.1155/2017/2925869. Epub 2017 Mar 5. Review.

4.

Tumor microenvironment: driving forces and potential therapeutic targets for breast cancer metastasis.

Xie HY, Shao ZM, Li DQ.

Chin J Cancer. 2017 Mar 29;36(1):36. doi: 10.1186/s40880-017-0202-y. Review.

5.

Understanding cell signaling in cancer stem cells for targeted therapy - can phosphoproteomics help to reveal the secrets?

Gruber W, Scheidt T, Aberger F, Huber CG.

Cell Commun Signal. 2017 Mar 29;15(1):12. doi: 10.1186/s12964-017-0166-1. Review.

6.

Glycophenotype of breast and prostate cancer stem cells treated with thieno[2,3-b]pyridine anticancer compound.

Mastelić A, Čikeš Čulić V, Režić Mužinić N, Vuica-Ross M, Barker D, Leung EY, Reynisson J, Markotić A.

Drug Des Devel Ther. 2017 Mar 14;11:759-769. doi: 10.2147/DDDT.S121122. eCollection 2017.

7.
8.

Ovarian cancer stem cells: still an elusive entity?

Lupia M, Cavallaro U.

Mol Cancer. 2017 Mar 20;16(1):64. doi: 10.1186/s12943-017-0638-3. Review.

9.

Vasculogenic mimicry signaling revisited: focus on non-vascular VE-cadherin.

Delgado-Bellido D, Serrano-Saenz S, Fernández-Cortés M, Oliver FJ.

Mol Cancer. 2017 Mar 21;16(1):65. doi: 10.1186/s12943-017-0631-x. Review.

10.

Enhanced Directional Migration of Cancer Stem Cells in 3D Aligned Collagen Matrices.

Ray A, Slama ZM, Morford RK, Madden SA, Provenzano PP.

Biophys J. 2017 Mar 14;112(5):1023-1036. doi: 10.1016/j.bpj.2017.01.007.

PMID:
28297639
11.

Abseq: Ultrahigh-throughput single cell protein profiling with droplet microfluidic barcoding.

Shahi P, Kim SC, Haliburton JR, Gartner ZJ, Abate AR.

Sci Rep. 2017 Mar 14;7:44447. doi: 10.1038/srep44447.

12.

Alternative therapies for metastatic breast cancer: multimodal approach targeting tumor cell heterogeneity.

Sambi M, Haq S, Samuel V, Qorri B, Haxho F, Hill K, Harless W, Szewczuk MR.

Breast Cancer (Dove Med Press). 2017 Feb 28;9:85-93. doi: 10.2147/BCTT.S130838. eCollection 2017. Review.

13.

Integrin-β4 identifies cancer stem cell-enriched populations of partially mesenchymal carcinoma cells.

Bierie B, Pierce SE, Kroeger C, Stover DG, Pattabiraman DR, Thiru P, Liu Donaher J, Reinhardt F, Chaffer CL, Keckesova Z, Weinberg RA.

Proc Natl Acad Sci U S A. 2017 Mar 21;114(12):E2337-E2346. doi: 10.1073/pnas.1618298114. Epub 2017 Mar 7.

14.

Melanoma cells undergo aggressive coalescence in a 3D Matrigel model that is repressed by anti-CD44.

Wessels D, Lusche DF, Voss E, Kuhl S, Buchele EC, Klemme MR, Russell KB, Ambrose J, Soll BA, Bossler A, Milhem M, Goldman C, Soll DR.

PLoS One. 2017 Mar 6;12(3):e0173400. doi: 10.1371/journal.pone.0173400. eCollection 2017.

15.

Prognostic factors of palatal mucoepidermoid carcinoma: a retrospective analysis based on a double-center study.

Xu W, Wang Y, Qi X, Xie J, Wei Z, Yin X, Wang Z, Meng J, Han W.

Sci Rep. 2017 Mar 6;7:43907. doi: 10.1038/srep43907.

16.

Liposomal Nanoparticles Carrying anti-IL6R Antibody to the Tumour Microenvironment Inhibit Metastasis in Two Molecular Subtypes of Breast Cancer Mouse Models.

Guo C, Chen Y, Gao W, Chang A, Ye Y, Shen W, Luo Y, Yang S, Sun P, Xiang R, Li N.

Theranostics. 2017 Jan 26;7(3):775-788. doi: 10.7150/thno.17237. eCollection 2017.

17.

Sulfasalazine attenuates evading anticancer response of CD133-positive hepatocellular carcinoma cells.

Song Y, Jang J, Shin TH, Bae SM, Kim JS, Kim KM, Myung SJ, Choi EK, Seo HR.

J Exp Clin Cancer Res. 2017 Mar 3;36(1):38. doi: 10.1186/s13046-017-0511-7.

18.

Regulation of stem-like cancer cells by glutamine through β-catenin pathway mediated by redox signaling.

Liao J, Liu PP, Hou G, Shao J, Yang J, Liu K, Lu W, Wen S, Hu Y, Huang P.

Mol Cancer. 2017 Feb 28;16(1):51. doi: 10.1186/s12943-017-0623-x.

19.

The epithelial to mesenchymal transition (EMT) and cancer stem cells: implication for treatment resistance in pancreatic cancer.

Zhou P, Li B, Liu F, Zhang M, Wang Q, Liu Y, Yao Y, Li D.

Mol Cancer. 2017 Feb 28;16(1):52. doi: 10.1186/s12943-017-0624-9. Review.

20.

Low-dose radiation decreases tumor progression via the inhibition of the JAK1/STAT3 signaling axis in breast cancer cell lines.

Kaushik N, Kim MJ, Kim RK, Kumar Kaushik N, Seong KM, Nam SY, Lee SJ.

Sci Rep. 2017 Feb 27;7:43361. doi: 10.1038/srep43361.

Supplemental Content

Support Center